STAT

Schrödinger CEO Ramy Farid discusses shifting perspectives on AI, anticipating clearer understanding of its capabilities in five years and reduced uncertainty in the job market and AI's role. The article highlights evolving AI strategies at Schrödinger and Centene.

Transgender federal employees are suing over the revocation of their health coverage. The lawsuit highlights a dispute regarding healthcare access for transgender individuals within the federal workforce.

The article is an opinion piece rebutting a recent op-ed's inaccuracies about a Covid study. It highlights STAT's platform, First Opinion, which publishes essays and Letters to the Editor for discussion in the life sciences field.

The Ebola outbreak is nearing a milestone, and a vaccine is close to being available. The article is reported by STAT's Morning Rounds newsletter.

The article argues that the United States' reliance on China poses a national security threat. It is an opinion piece published on STAT's First Opinion platform, which features discussions on life sciences topics.

Anthony Fauci’s pandemic-era diary entries are featured in a story by STAT’s Jason Mast. The article is part of STAT’s Morning Rounds newsletter, which provides daily health and medicine updates.

The article discusses the persistence of ultra-processed baby foods as a trend and mentions STAT’s Morning Rounds newsletter covering health topics like cyclosporiasis and measles. It highlights the newsletter’s focus on daily health and medicine updates.

A new outbreak of a diarrhea-causing parasite has been reported. The article also mentions a friend's advice about taking multiple peptides for potential health benefits.

Lawmakers are rushing to pass health care bills before the House and Senate adjourn together until Sept. 14. The article highlights a flurry of legislative activity as each chamber will later operate independently for part of the remaining session.

The FDA's peptide panel is expected to have a clash today. The panel will discuss peptides over two days, as noted in STAT's Morning Rounds newsletter.

Trump promised redemption for military personnel who refused Covid-19 vaccines, but a year later, many remain unaddressed. The article, co-published by STAT and The War Horse, highlights the ongoing uncertainty among troops.

A new study finds increasing job dissatisfaction and uncertainty about healthcare access in the U.S. The article also mentions a related First Opinion essay and office hours with Bob Herman, a health care business chronicler at STAT.

The article discusses a renewed political push from the right against abortion pills and mentions a story on THC beverages by Sarah Todd. It also promotes STAT’s Morning Rounds newsletter.

Novo Nordisk lists telehealth company LifeMD as a provider for GLP-1 drugs, but former employees allege the firm prioritizes prescription volume over patient safety. An Iowa Medicaid audit found pharmacy benefit managers overcharged taxpayers by over $100 million through complex billing practices.

The HHS vaccine committee has received a new charter, though the change was made quietly without significant public attention.

STAT's First Opinion platform publishes articles on primary care, obesity as a disease, and other life sciences topics, along with selected Letters to the Editor from readers. Submissions are encouraged through a designated form.

The article discusses access to testosterone hormone medication in the U.S. and mentions STAT’s free health newsletter Morning Rounds. It also notes wildfire smoke affecting Brooklyn.

UnitedHealth Group exceeded second-quarter earnings expectations, boosting its stock, but warned of increasing financial strain on employers and workers due to rising health insurance costs. A new STAT series highlights how small businesses are abandoning traditional health benefits, forcing employees to seek alternatives.

The Alzheimer’s Association International Conference highlighted advancements in blood-based biomarker tests for Alzheimer’s, aiming to make diagnostics more accessible and move testing to primary care settings. The Alzheimer’s Association has issued guidelines for their use.

An analysis of 52,322 public comments on a White House proposal to overhaul federal grantmaking found 95% opposition and 1% support. The study, conducted by researchers at the University of North Carolina at Chapel Hill in partnership with STAT, used a large language model to assess sentiment and identify themes.

The article discusses the risks associated with refusing a vitamin K shot for newborns. It also mentions STAT’s free health newsletter, Morning Rounds, and highlights recent reporting by journalists Bob Herman and Rose Broderick.

Alcohol kills over 178,000 Americans annually, driven by policy decisions, industry influence, and cultural inertia. The U.S. has not implemented significant efforts to reduce heavy drinking since the end of Prohibition nearly a century ago.

Alcohol-related deaths in the U.S. exceed those from all illicit drugs combined, yet the issue remains under-addressed. Emergency department visits linked to alcohol nearly doubled between 2003 and 2022, with alcohol-related hospitalizations outpacing those from opioids in many states.

The article highlights the focus on Tau at the Alzheimer’s Association International Conference (AAIC) in London. It promotes a special report by STAT on dementia diagnostics, treatments, and care, offering a discounted price for conference attendees using the code 'AAIC'.

A whistleblower challenges an insurance contractor over high family health insurance costs, while potential candidates for the new FDA commissioner are discussed on 'The Readout LOUD' podcast. The episode explores rising health insurance prices and regulatory leadership changes.

The article poses the question of who will lead the FDA and mentions STAT's free health newsletter, Morning Rounds, while referencing a World Cup match between France and Morocco.

The article mentions an upcoming significant increase in premiums and references a historical event related to the Declaration of Independence. It also promotes STAT’s free health and medicine newsletter, Morning Rounds.

A 'secret shopper' study investigates GLP-1 telehealth sites, as STAT's Health Tech newsletter highlights rising healthcare costs through a new series. The article focuses on technology's role in transforming life sciences and explores the financial burden of healthcare despite employer-provided insurance.

The article discusses how an Ebola outbreak has revealed weaknesses in the outbreak response system. It mentions STAT's Morning Rounds newsletter as a source for health and medicine updates.

Over 150 million Americans rely on job-based health insurance, but small companies are increasingly unable to afford coverage, with fewer than 60% of firms with 200 or fewer workers offering insurance—a record low. Rising costs are forcing small businesses to reduce benefits or drop coverage entirely, threatening employee retention.

America’s small businesses are increasingly abandoning health insurance due to rising costs and unaffordable options. The percentage of working-age adults with job-based health coverage has dropped from 67% in 1998 to about 60%, as high premiums driven by hospital, doctor, and drug prices strain businesses and workers.

The article discusses the mental health challenges faced by content creators, highlighting a conference in Anaheim, Calif., (Vidcon) where programming focused on their well-being. The author, who creates social media content for STAT, notes the growing attention to mental health implications for creators with large audiences.

The FDA has approved Zyn to market its nicotine pouches as safer than cigarettes. The article also mentions STAT’s free health newsletter and a temporary substitution in its editorial team.

The Supreme Court ruled in a case involving a weedkiller and cancer. The article also mentions a health newsletter and Pride Weekend celebrations in New York City.

The Department of Justice's campaign against trans health faces another roadblock. The article mentions a newsletter signup but provides limited additional details on the issue.

The FDA analyzed its own data on youth tobacco use. The article highlights strong reporting by Lizzy on a patient who received retatrutide, though the focus remains on the FDA's delayed action regarding youth tobacco data.

The White House denied a report suggesting President Trump received the investigational obesity drug retatrutide. STAT reported that Eli Lilly and the FDA approved a compassionate use request for the medication.

A man was granted compassionate-use access to an experimental GLP-1 drug developed by Eli Lilly. The exclusive report details the sole individual given special access to the obesity treatment, as covered in STAT's health policy newsletter.

Pfizer disclosed that its experimental lung cancer drug, sigvotatug vedotin, failed to show a statistically significant improvement over docetaxel in a clinical trial. The U.S. Food and Drug Administration announced a pilot program to accelerate early-stage clinical trials, aiming to reduce development timelines and counter Chinese dominance in the field.

The U.S. Department of Health and Human Services (HHS) has sent a drug for an Ebola clinical trial. The article also mentions STAT's free health newsletter, Morning Rounds, and open nominations for the next class of STAT Wunderkinds.